H.R. 2241 · 114th Congress
Global Health Innovation Act of 2015
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 114th Congress ended.
D
SiresSponsor21 cosponsors · 14 D, 7 R
R
Diaz-Balart
IR
R
Ros-Lehtinen
AC
R
Crenshaw
GM
D
Meeks
SD
D
DelBene
AG
D
Green
GC
D
Connolly
RG
D
Grijalva
TL
D
Lieu
SS
R
Stivers
CS
R
Smith
DD
R
Donovan
EE
D
Engel
BH
D
Higgins
WK
D
Keating
GM
D
Meng
BP
D
Pascrell
BS
D
Sherman
DC
D
Cicilline
DR
R
Reichert
BM
D
McCollum1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced May 5, 2015
- House Passed Dec 18, 2015
What it does: CRS summary · Passed House amended · Dec 18, 2015
Global Health Innovation Act of 2015
(Sec. 2) This bill directs the U.S. Agency for International Development (USAID) to report annually for four years to Congress regarding:
- the extent to which global health innovations include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations;
- how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases;
- how goals are set for health product development in relation to USAID's health-related goals;
- how USAID is leveraging U.S. investments to achieve greater impact in health innovation, developing and introducing affordable global health products, and increasing health innovations in the development pipeline;
- how USAID is coordinating with other federal departments and agencies in support of global health product development; and
- how USAID is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Global Health Innovation Act of 2015
Latest action (Dec 18, 2015): Received in the Senate and Read twice and referred to the Committee on Foreign Relations.
Policy area: International Affairs · Origin: House · Introduced: May 5, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced May 5, 2015
- House Passed Dec 18, 2015
No recorded floor vote found.